Therapeutics that Improve Control Systems (Tier 2)

  • 08-15-2016

  • Pledge

  • $0.00-$0.00

  • Limited -- TBD

  • $12,600.00 show details

  • Apple, GSK, Giliad, Google, Medtronic, Nestle, Roche, Takeda, Verily

  • BIO (Industry Organization), MDMA (Medical Device Manufacturers Association)

  • Biotechnology, Pharma, Medical Devices, Healthcare Services

  • Drugs, Medical Devices, Bioelectronics, Aging, Fertility

  • Joon to write-up

ALL APPLICATIONS

Patent Type Serial # Client Filed Status Latest Trans. Title
Patent 14/537,672 Palo Alto Investors 11-10-2014 Patented Case Issue Notification Methods And Devices For Treating Conditions Associated With Autonomic Dysfunction
Patent 13/592,102 Palo Alto Investors 08-22-2012 Patented Case Issue Notification Methods And Devices For Treating Conditions Associated With Autonomic Dysfunction
Patent 11/060,643 Palo Alto Investors 02-16-2005 Patented Case Notice of Change of Address placed in File Wrapper due to EBC Customer Number update Treatment Of Conditions Through Modulation Of The Autonomic Nervous System
Patent 10/661,368 Palo Alto Investors 09-12-2003 Patented Case Notice of Change of Address placed in File Wrapper due to EBC Customer Number update Treatment Of Conditions Through Electrical Modulation Of The Autonomic Nervous System
Patent 10/917,270 Palo Alto Investors 08-11-2004 Patented Case EFS Acknowledgment Receipt Methods Of Treating A Subject For A Condition
Patent Application 11/343,940 Palo Alto Investors 01-30-2006 On Appeal -- Awaiting Decision by the Board of Appeals Appeal Docketing Notice Methods And Compositions For Treating A Disease Condition In A Subject
Patent Application 14/035,814 Palo Alto Investors 09-24-2013 Final Rejection Mailed Examiner's search strategy and results Methods Of Treating A Subject For A Condition
Patent Application 11/592,027 Palo Alto Investors 11-01-2006 Response to Non-Final Office Action Entered and Forwarded to Examiner Fee Worksheet (SB06) Methods And Compositions For Treating A Renal Disease Condition In A Subject
Patent Application 12/774,616 Palo Alto Investors 05-05-2010 On Appeal -- Awaiting Decision by the Board of Appeals Appeal Docketing Notice Treatment Of Conditions Through Modulation Of The Autonomic Nervous System
Patent Application 14/303,492 Palo Alto Investors 06-12-2014 Appeal Brief (or Supplemental Brief) Entered and Forwarded to Examiner EFS Acknowledgment Receipt Methods For Treating Conditions By Restoring Central Nervous System Endocrine Gland Function, And Compositions And Devices For Practicing The Same